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Abstract 
Background: The pathogenesis of pulmonary oedema (PE) in patients with severe malaria is still unclear. It has been 
hypothesized that lung injury depends, in addition to microvascular obstruction, on an increased pulmonary capillary 
pressure and altered alveolar-capillary membrane permeability, causing pulmonary fluid accumulation.
Methods: This study compared the histopathological features of lung injury in Southeast Asian patients (n = 43) 
who died from severe Plasmodium falciparum malaria, and correlated these with clinical history in groups with or 
without PE. To investigate the expression of mediators that may influence fluid accumulation in PE, immunohisto-
chemistry and image analysis were performed on controls and sub-sets of patient with or without PE.
Results: The expression of leukocyte sub-set antigens, bronchial interleukin (IL)-33, γ-epithelium sodium channel 
(ENaC), aquaporin (AQP)-1 and -5, and control cytokeratin staining was quantified in the lung tissue of severe malaria 
patients. Bronchial IL-33 expression was significantly increased in severe malaria patients with PE. Malaria patients with 
shock showed significantly increased bronchial IL-33 compare to other clinical manifestations. Bronchial IL-33 levels 
were positively correlated with CD68+ monocyte and elastase + neutrophil, septal congestion and hyaline mem-
brane formation. Moreover, the expression of both vascular smooth muscle cell (VSMC) and bronchial γ-ENaC signifi-
cantly decreased in severe malaria patients with PE. Both VSMC and bronchial γ-ENaC were negatively correlated with 
the degree of parasitized erythrocyte sequestration, alveolar thickness, alveolar expansion score, septal congestion 
score, and malarial pigment score. In contrast AQP-1 and -5 and pan cytokeratin levels were similar between groups.
Conclusions: The results suggest that IL-33 may play a role in lung injury during severe malaria and lead to PE. Both 
VSMC and bronchial γ-ENaC downregulation may explain pulmonary fluid disturbances and participate in PE patho-
genesis in severe malaria patients.
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Background
Malaria infection caused by Plasmodium falciparum con-
tinues to be a major cause of death in tropical countries. 
Death in falciparum malaria is a consequence of multiple 
vital organ dysfunction, including cerebral malaria (CM), 
anaemia, acidosis, renal failure, and respiratory insuffi-
ciency [1]. The degree and type of lung involvement var-
ies between cases, some patients show no involvement or 
minor symptoms such as cough, other show chest X-ray 
(CXR) changes or develop respiratory distress, or pro-
gress to frank pulmonary oedema or acute respiratory 
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distress syndrome (ARDS), the cause of death in adults 
with severe malaria-associated lung injury [2–4]. Hospi-
tal-based case series of severe malaria have reported clin-
ical development of pulmonary oedema (PE) in 9–23  % 
of patients [5–7]. Autopsy studies [8, 9] in patients dying 
from severe falciparum malaria have revealed heavy 
oedematous lungs, congested pulmonary capillaries, 
thickened alveolar septa, intra-alveolar haemorrhages, 
hyaline membrane formation, and serous pleural as well 
as pericardial effusions. Microscopically, in addition to 
alveolar oedema and haemorrhages, the alveolar capil-
laries are filled with sequestrated P. falciparum-infected 
red blood cells and host leukocytes, such as malarial 
pigment-laden macrophages. Clinical and pathological 
evidence suggests that this is a non-cardiogenic form of 
PE [10–12]. In some series pulmonary involvement is as 
common as coma [13, 14].
The pathophysiology of impaired lung function in falci-
parum malaria is poorly understood, but has been stud-
ied in murine models of experimental severe malaria. It 
is likely to involve both pathogen-induced changes such 
as pulmonary microvascular obstruction by parasitized 
red blood cells (PRBCs) [15], malaria pigment associated 
lung injury [16] and host factors, such as soluble cytokine 
release [17] and leukocyte responses. Other groups 
have hypothesized that lung injury following treat-
ment of malaria may be predominantly an inflammatory 
response, rather than purely a microvascular obstructive 
phenomenon, as evidenced by abnormal gas transfer and 
lung symptoms in both uncomplicated (mild) falciparum 
malaria, and lung injury in other malarias such as Plas-
modium vivax [18].
Although lung pathology has been a relatively 
neglected area in the study of malaria complications [19], 
understanding the pathophysiology must account for the 
range of symptoms seen in patients. Where frank acute 
PE develops, this is may be a poor prognosis sign and a 
terminal event, possibly reflecting brainstem injury in 
comatose patients and neurogenic in origin. In patients 
with ‘algid’ malaria, characterized by cardiogenic shock, 
oedema may result from aggressive fluid resuscitation. 
However a lesser degree of PE, and other lung infiltrates 
on CXR are common, which argues for a direct pulmo-
nary pathogenesis in some cases [3].
In the normal lung, fluid moves from the blood circu-
lation through the capillary endothelium into the lung 
interstitium and then is cleared by the lymphatics on a 
continuous basis [20]. When the permeability of capil-
lary walls is increased, as in acute lung injury (ALI), the 
quantity of fluid that leaves the pulmonary microcircu-
lation is increased to a point that overwhelms the clear-
ance capacity of the lymphatics leading to interstitial 
oedema (hydrostatic oedema) [21]. However, eventually 
alveolar oedema (permeability oedema) will develop if 
the amount of interstitial oedema overwhelms the epithe-
lial barrier and overflows into the airspaces [20]. Clear-
ance of PE fluid is accomplished by active ion transport, 
especially by the alveolar epithelium [20]. The molecular 
mechanisms through which oedema formation is regu-
lated in the lung are complex. The current paradigm for 
liquid homeostasis in the adult mammalian lung is that 
passive apical uptake of sodium via the amiloride-sen-
sitive epithelial Na+ channel (ENaC) creates the major 
driving force for re-absorption of water through the alve-
olar epithelium in addition to other ion channels, such 
as potassium and chloride channels [22]. ENaC can be 
expressed on both bronchial epithelium but also vascu-
lar smooth muscle cell (VSMC) in bronchial walls. Other 
water transport membrane proteins may also have a role. 
To date, 13 different aquaporins (AQPs) have been iden-
tified in mammalian cells [23]. In the respiratory system, 
AQP-1 is localized in microvascular endothelial cells 
and AQP-5 in the apical side of epithelium cells [24, 25]. 
Recent evidence has suggested a role for AQP-1 and -5 
in maintenance of fluid homeostasis in the lung [25–29], 
and some alterations due to tissue damage may lead to 
pathophysiologic conditions [30–33].
In experimental model, sepsis induced acute lung 
injury, Interleukin (IL)-33 deficient mice exhibit reduced 
mortality and cytokine release [34]. IL-33 is a newly char-
acterized member of the IL-1 superfamily of cytokines 
that is mainly expressed by epithelial cells, and its expres-
sion is upregulated following pro-inflammatory stimu-
lation. It is thought to function as an ‘alarmin’, released 
following cell necrosis to alert the immune system to tis-
sue damage or stress [35]. IL-33 also is involved in T cell-
mediated immune responses and functions as a central 
regulator of human auto-immune diseases [36].
In this study, the histopathological features of lung 
involvement in 43 adult Thai patients dying of severe 
falciparum malaria were examined in post-mortem lung 
samples and ten trauma cases as normal controls. Sub-
sets of malaria patients either with or without histological 
evidence of PE were then examined using immunohisto-
chemistry to investigate leukocyte sub-set localization 
(including CD3, CD8, CD68, and neutrophil elastase), 
the expression of bronchial IL-33, γ-ENaC, AQP-1 and 
-5, and pancytokeratin as a control. Histopathological 
features such as septal thickness and immunolocaliza-
tion of staining were further analysed using digital image 
analysis. The correlation between the expression of these 
markers, histopathological and clinical parameters was 
evaluated to determine whether IL-33, any distinct sub-
types of host leukocytes, γ-ENaC, and AQP-1 and -5 
were associated with the development of PE in severe 
malaria lung injury.
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Methods
Ethical permission
This research protocol was approved by the Ethics Com-
mittee of the Faculty of Tropical Medicine, Mahidol 
University, Thailand (approval number MUTM2012-
032-01). The Ethics Committee waived the need for con-
sent since this study was the leftover specimen study. All 
relevant clinical data were permitted and obtained from 
Hospital for Tropical Diseases, Thailand and analysed 
anonymously.
Sample collection
This study used formalin-fixed, paraffin-embedded speci-
mens of lung tissue previously collected at post mortem 
from patients who died from severe falciparum malaria 
at Hospital for Tropical Diseases, Thailand, between 
1969 and 2004. Lung specimens were fixed in 10 % for-
malin at autopsy and processed using standard histo-
logical techniques, and stored as paraffin-embedded 
blocks. All patients had careful admission clinical exami-
nation and investigations. On admission, the presence 
of a sexual P. falciparum blood stages in the peripheral 
blood was detected by routine parasitological examina-
tion all patients. Severe malaria was classified accord-
ing to WHO criteria as the presence of one or more of 
the following complications: a Glasgow Coma score of 
less than 11 (CM, anaemia, jaundice, renal failure, PE, 
hypoglycaemia, shock, and hyperparasitaemia) [37]. As 
well as severe falciparum malaria, some patients had evi-
dence of either clinical pneumonia (increased respiratory 
rate +  intercostal indrawing with or without consolisa-
tion on CXR).
Histological study
Histopathological examination was conducted on 
standard 4 micron thickness, haematoxylin and eosin 
(H&E)-stained slides of the malaria lung (n = 43 includ-
ing non-PE = 15, PE = 28). These were assessed for the 
presence of PE, alveolar wall expansion, septal conges-
tion, PRBC sequestration, malarial pigment, intra-alveolar 
haemorrhage, hyaline membrane formation, and accumu-
lation of leukocytes (WBC). Septal congestion was deter-
mined by the increasing of alveolar thickness with cells 
including WBC, red blood cell (RBC), and PRBC, while 
alveolar wall expansion was categorized by its expansion 
with increased alveolar epithelium cells and/or hyaline 
membrane formation without cellular congestion. Cases 
were defined as showing evidence of PE if more than 
25 % of the alveolar spaces in the section contained free 
fluid. The overall histopathological grade of each feature 
was classified as: 0 = absent, +1 =  focal (less than 25 % 
of section), +2 =  present (between 25 and 50  % of sec-
tion) and +3 = severe (more than 50 % of section). These 
morphological parameters were compared with normal 
lung tissue from controls, consisting of trauma cases 
(n = 10) with no gross pathological changes at autopsy or 
on subsequent histological examination of the lung. His-
topathological parameters were fully blind-graded by two 
observers (SA and GT). A third person (EP) was asked for 
additional grading when more than 2 score was observed. 
Complete clinical data were available in 31/43 cases (11 
non-PE and 20 cases with PE).
Immunohistochemistry study
Nine markers, all T-cells (CD3), cytotoxic T cell (CD8), 
monocyte/macrophage (CD68), neutrophil elastase, 
IL-33, γ-ENaC, AQP-1 and -5, and pan cytokeratin 
(AE1/AE3), were used as described in Table  1. Four 
micron thick sections from the paraffin blocks were cut 
and placed on precoated immunohistochemistry slides, 
dried overnight at 56  °C then allowed to cool. The sec-
tions were deparaffinized in xylene and rehydrated prior 
to immunostaining.
Heat-induced antigen retrieval with citrate buffer, 
pH 6 or EDTA Tris buffer, pH 9 was used to unmask 
the antigen depending on the optimized method for 
Table 1 Primary antibodies used in the study
Antibodies Type Source Dilution Measuring site
CD3 Mouse monoclonal DakoCytomation® 1:100 All T-lymphocyte
CD8 Mouse monoclonal DakoCytomation® 1:100 Cytotoxic T-lymphocyte
CD68 Mouse monoclonal DakoCytomation® 1:200 Macrophage
Neutrophil elastase Mouse monoclonal DakoCytomation® 1:200 Neutrophil
IL-33 Rabbit polyclonal Milipore® 1:100 Bronchial epithelium
γ-ENaC Rabbit polyclonal Milipore® 1:100 Bronchial epithelium
Vascular smooth muscle cell
AQP-1 Rabbit polyclonal Milipore® 1:100 Alveolar capillary
AQP-5 Rabbit polyclonal Milipore® 1:50 Alveolar epithelium
Pan cytokeratin Rabbit polyclonal Milipore® 1:400 Bronchial epithelium
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each antibody, according to manufacturer’s instruc-
tions. Endogenous peroxidase was quenched with 3  % 
v/v hydrogen peroxide in methanol after sections were 
cooled. Sections were washed with 0.2 % v/v Tween in 
phosphate buffered saline (0.2  % T-PBS) and blocked 
with protein block serum free (Dako, Denmark, X0909) 
for 10  min. Sections were incubated primary antibody 
diluted in PBS with 1  % v/v normal goat serum (NGS, 
Vector, USA, S1000), washed three times in 0.2  % 
T-PBS and incubated for 30 min with labelled polymer 
HRP antimouse/rabbit EnVision kit (Dako, Denmark, 
K5007) at room temperature, according to manufac-
turer instruction, and visualized with diaminobenzidine 
(DAB, DAKO, Denmark, K3468) for 3  min, then the 
sections washed and counterstained with haematoxylin 
and permanently mounted with DPX.
Quantitative assessment of leukocyte immunostaining
The number of leukocytes in the lung sections was quan-
titated by the number of immunopositive cells counted 
in ten randomly selected high power (×400) fields. The 
criteria for definite positive cell staining were cytoplas-
mic or membrane staining with the relevant antibody in 
a section where the nucleus of the particular cell can be 
seen.
Assessment of bronchial immunohistochemistry 
for bronchial IL‑33, pan cytokeratin, and γ‑ENaC using 
digital image analysis
In each group, five random fields (at ×400) were exam-
ined for all observed bronchi. From each specimen, col-
our images of 640 × 480 pixel resolution were acquired 
with a light microscope (BX51, Olympus®) and digi-
tal camera (DP20, Olympus®). Immunohistochemical 
expression was then be analysed by semi-quantitative dig-
italized image analysis using ImageJ, NIH® [38]. Briefly, 
colour images were first converted to 8-bit image in grey 
scale. Adjusted images were transformed by threshold 
mode to locate the interested area. The polygon selection 
mode was used to outline the area of bronchus. Then, the 
area of positive immunostaining was estimated by the 
number of black pixels within measuring mode. Thus, the 
area fraction of positive reaction was determined as the 
percentage of black pixels/bronchus area.
Image analysis for assessment of alveolar thickness
In each case, multiple random fields (at ×400) were 
examined to assess the thickness of the alveolar septum. 
Ten random colour images of 640 × 480 pixel resolution 
were acquired as above. Alveolar thickness was measured 
(5 thickness/image) by straight-line selection mode after 
length calibration by set scale mode using the image anal-
ysis software ImageJ, NIH®.
Assessment of arterial immunohistochemistry for VSMC 
γ‑ENaC
In each case, multiple random fields (at ×400) were 
examined for ten arteries. Colour images were acquired, 
and then the expression area of VSMC γ-ENaC was ana-
lysed as previously described using the tunica media as 
the denominator measurement.
Assessment of alveolar immunohistochemistry for AQP‑1 
and ‑5
Ten random fields (at ×400) were examined for alveolar 
septa. From each specimen, colour images were acquired, 
and the expression area of AQP-1 staining on alveolar 
vessels and AQP-5 staining on alveolar epithelium was 
analysed as previously mentioned using total alveolar 
vessel wall or septal length, respectively, as a denomina-
tor measurement.
Statistical analysis
Data were statistically analysed with IBM® SPSS® Sta-
tistic software version 20. Kruskal-Wallis test was used 
to compare area of expression of AQP-1 and -5, pan-
cytokeratin, γ-ENaC and IL-33 among normal, PE and 
non-PE lungs. Spearman’s correlation test was used to 
determine the correlation between measured parameters. 
The proportion of each clinical complication was com-
pared between PE and non-PE groups by Chi-square test. 
Histopathological score and number of leukocyte sub-
sets were compared by each clinical complication using 
Mann–Whitney U test. The criterion for significance was 
considered as p value less than 0.05.
Results
Clinical data
Clinical manifestations and parameters in severe malaria 
patients are described in Table  2. The clinical signs of 
PE in adults did not differ from that of younger patients, 
[75.0 % (15/20) and 45.5 % (5/11), respectively, p = 0.132]. 
The age, parasitaemia on admission and percentage of 
PRBC sequestration were not different between non-PE 
and PE patients. There was no difference in patterns of 
clinical manifestations of severe malaria between non-PE 
and PE patients, apart from anaemia and acidosis, which 
were significantly more frequent in non-PE patients 
(p = 0.012 and 0.013, respectively).
Histopathology
Lung sections from patients with severe malaria showed 
PRBC sequestration, alveolar wall expansion, septal con-
gestion, accumulation of malarial pigment-laden mac-
rophages, neutrophils, and other WBCs, intra-alveolar 
haemorrhages, and hyaline membrane formation. Of 
43 patients with severe malaria enrolled in the study, 28 
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(~65  %) had evidence of PE. Histopathological scores 
among PE, non-PE, and normal lungs are showed in 
Fig. 1. All parameters exhibited significantly lower scores 
in normal lung. The scores were not different between 
PE and non-PE except for hyaline membrane forma-
tion, which was significantly higher in PE than in non-PE 
and control lungs. The occurrence of hyaline membrane 
formation, indicating diffuse alveolar damage (and cor-
relating with the clinical development of ARDS) did not 
differ between adult patients (≥18 years old) and paedi-
atric patients (<18 years old), [35.0 % (7/20) and 36.3 % 
(4/11), respectively, p =  0.675]. Image analysis revealed 
that alveolar septal thickness was not significantly differ-
ent among normal, PE, and non-PE lungs (17.41 ± 9.20, 
23.29 ± 10.14 and 20.97 ± 22.11, respectively, p = 0.747).
Bronchial IL‑33
Bronchial IL-33 expression was significantly higher in 
cases with PE than in the non-PE and normal lungs 
(Fig.  2a). While there was a significantly negative cor-
relation between bronchial IL-33 expression and CD8+ 
T-cell accumulation (number/hpf), a significantly posi-
tive correlation was found between bronchial IL-33 
expression and CD68+ monocyte accumulation (num-
ber/hpf), elastase  +  neutrophils (number/hpf), sep-
tal congestion score, total leukocyte score, and hyaline 
membrane formation score (Fig.  2b). Moreover, the 
patients who showed co-existent clinical signs of shock 
in severe malaria exhibited significantly higher bronchial 
IL-33 expression (Fig. 2c).
Leukocyte sub‑set accumulation
The numbers of CD3, CD8, CD68 cells, and neutro-
phils were not different among non-PE, PE, and normal 
lungs (Fig.  3a). However a significantly positive correla-
tion between CD68 and septal congestion score, malar-
ial pigment score and PRBCs score was found (Fig. 3b). 
The patients who showed the clinical signs of shock 
also exhibited significantly higher numbers of neutro-
phils while there was no difference in leukocyte subsets 
in relation with these signs (Fig.  3c). Also, the number 
of neutrophils was not different between patients with 
Table 2 Clinical data, histopathological changes and clinical complications of severe malaria cases
Parameter Non‑PE PE p value
Clinical data and complication
 Age (years) 5–42 (20.8 ± 14.6) 3–54 (24.5 ± 13.4) 0.485
 Parasitaemia/µl on admission 412,042.72 ± 224,608.34 594,576.50 ± 822,975.64 0.480
 % PRBC sequestration 65.5 ± 40.68 74.0 ± 36.18 0.552
 Anaemia (%) 100 (11/11) 55 (11/20) 0.012
 Jaundice (%) 54.5 (6/11) 80 (16/20) 0.217
 Pneumonia (%) 45.5 (5/11) 45 (9/20) 1.000
 Acute renal failure (%) 27.3 (3/11) 30 (6/20) 1.000
 Acidosis (%) 63.6 (7/11) 15 (3/20) 0.013
 Shock (%) 9.1 (1/11) 20 (4/20) 0.631
 Systemic bleeding (%) 9.1 (1/11) 20 (4/20) 0.631
 Hypoglycaemia (%) 18.2 (2/11) 5 (1/20) 0.281
 Cerebral malaria (%) 63.6 (7/11) 70 (14/20) 1.000
Histopathological changes (median score)
 Alveolar expansion 1.46 ± 1.24 1.64 ± 0.95 0.607
 Septal congestion 1.73 ± 1.09 1.78 ± 0.68 0.848
 Malarial pigment 1.73 ± 1.09 2.00 ± 0.86 0.385
 Alveolar haemorrhage 0.93 ± 1.09 1.03 ± 1.13 0.778
 PRBCs sequestration 1.46 ± 1.12 1.42 ± 0.95 0.908
 WBC accumulation 2.20 ± 0.77 2.00 ± 0.60 0.356
 Hyaline membrane formation 0.13 ± 0.35 0.39 ± 0.73 0.037
Treatments (number/cases)
 Quinine 3/11 11/20 –
 Artemeter 0/11 2/20 –
 Quinine and artesunate 0/11 1/20 –
 Artesunate and artemeter 1/11 0/20 –
 Data were not available 7/11 6/20 –
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Fig. 1 Histopathological changes in the lung in severe malaria. a Bar chart comparing score of the histopathological features in normal, non-PE and 
PE malaria lung samples; b, c photomicrographs of histopathological changes in a fatal falciparum malaria case [case number A41001]; b alveolar 
capillary expansion with accumulation of sequestration PRBCs and leukocytes accumulation. Phagocytosed haemozoin pigment in macrophages 
and neutrophils within alveolar septa; c pulmonary oedema and hyaline membrance formation indicated severe lung injury; d severe pulmonary 
oedema presented with free oedematous fluid in alveolar space [case number A47001-8]; and, e normal lung with clear alveolar space and thin 
alveolar septum [case number RC002-22], (H&E staining, scale bars as shown), For this and subsequent figures statistical significance of comparisons 
are *p < 0.05, **p < 0.01, ***p < 0.0001
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Fig. 2 Immunohistochemical expression of bronchial IL-33 expression is increased in malaria cases with pulmonary oedem. a Bar chart comparing 
of bronchial IL-33 expression in normal, non-PE and PE lung samples and photomicrographs of immunohistochemical staining of bronchial IL-33 
localization; b significance correlation plot of bronchial IL-33 expression to leukocyte count and histopathological score; c bar chart comparing of 
bronchial IL-33 expression to clinical manifestations
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Fig. 3 Alveolar leukocyte sub-set counts compared between clinical groups and histopathological features. a Bar chart comparing of leukocyte 
sub-sets count in normal, non-PE and PE lung samples and photomicrographs of immunohistochemical staining of leukocyte sub-sets localization; 
b significance correlation plot of leukocyte sub-sets count to histopathological score; c significance bar chart comparing of leukocyte sub-sets 
count to clinical manifestations
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(16.62  ±  24.95) and without (49.20  ±  101.58) hyaline 
membrane formation.
γ‑ENaC
ENaC staining was seen both on bronchial epithelium 
and vascular smooth muscle cell. Percentage expres-
sion areas of VSMC γ-ENaC were significantly lower in 
PE than in non-PE and normal lungs (Fig.  4) while the 
expression of bronchial γ-ENaC in both non-PE and PE 
were significantly lower than normal lungs (Fig.  5). The 
results also indicate a significantly negative correlation 
between both VSMC and bronchial γ-ENaC to alveo-
lar thickness (−0.251; p  <  0.001 and −0.349; p  <  0.001, 
respectively), alveolar expansion score (−0.141; p < 0.05 
and −0.306; p  <  0.001, respectively), septal congestion 
score (−0.141; p  <  0.05 and −0.257; p  <  0.01, respec-
tively), and malarial pigment score (−0.336; p < 0.001 and 
−0.196; p  <  0.05, respectively). Moreover, the patients 
who showed clinical signs of anaemia (10.03  ±  5.53 
compared to 14.13  ±  8.38, p  <  0.01) and pneumonia 
(9.01 ± 5.96 compared to 13.26 ± 7.59, p < 0.05) had sig-
nificantly decreased levels of bronchial γ-ENaC.
AQP‑1 and ‑5 and cytokeratin
AQP-1 stained endothelial cell, AQP-5 staining pattern 
on alveolar/bronchial epithelial cells. These patterns are 
similar to those shown in previous publications. The 
expression levels of alveolar AQP-1 and -5 scoring and 
bronchial cytokeratin were not significantly different 
between severe malaria patients with or without PE and 
healthy subjects (Fig.  6). The maintenance of staining 
for pancytokeratin across groups allowed comparison of 
changes in other markers, given the potential for loss of 
immunoreactivity in blocks stored for some years.
Discussion
Among clinical parameters, no manifestations of severe 
falciparum malaria were associated with a higher inci-
dence of PE, whilst only features which were associated 
with lower incidence of PE were anaemia and acido-
sis. Peripheral parasitaemia on admission did not differ 
between PE and non-PE patients, suggesting that multi-
organ dysfunction in this group of patients was not 
related to greater parasite burden, in agreement with 
the study of Gachot et  al. [13]. Quantitation of PRBC 
sequestration in the lung is a better correlate of tissue 
parasite burden but again this was not significantly dif-
ferent between cases with or without PE. CM and meta-
bolic acidosis are the most common manifestations of 
severe malaria in all age groups [39]. Severe anaemia, 
hypoglycaemia and convulsions are more common in 
semi-immune paediatric cases (typically in sub-Saharan 
Africa), whereas renal failure, severe jaundice, ALI, and 
ARDS are more frequent in adults [2, 3]. The present 
data showed a similar distribution of clinical manifesta-
tions in both adults and children (ranging from three to 
54 years old), but confirms the clinical and pathological 
occurrence of ALI in paediatric cases of severe malaria 
in Thailand. However, all of the specimens included in 
this study were historical samples, all clinical details 
were particularly not complete to obtain. Although anti-
malarial treatment was provided in Table  2, there were 
no available results of blood culture examination and 
supportive treatments history, such as pulmonary venti-
lation. These are the study’s limitation since septicaemia 
and tracheal intubation might also be a cause of PE and 
lowered γ-ENaC [40].
Pathological features of lung injury in the differ-
ent groups were heterogeneous. Although PE in severe 
malaria is characteristically patchy histologically, and we 
only examined one to two blocks per case, clinical find-
ings and a threshold pathological score (25 % of the sec-
tion showing free fluid in the alveolar space) were used 
as important criteria to differentiate PE and non-PE in 
this study. Some patients dying of malaria show minimal 
reaction even to high levels of PRBC and WBC seques-
tration, through PE to pneumonitis-like leukocyte infil-
tration of alveolar capillaries (which may show up on 
CXR as patchy infiltrates and be misdiagnosed as PE) to 
full blown ARDS. Ten patients in this study showed evi-
dence of hyaline membrane formation evidence of early 
diffuse alveolar damage (DAD), which is correlated with 
the clinical development of ARDS. PE is likely to be an 
early event and could be influenced by direct adhesive 
signalling events resulting from sequestration of PRBC 
and WBC, and immune-inflammatory network activa-
tion in reaction to that in alveolar capillaries. However 
other factors such as disturbance of epithelial function 
may also be important, hence examining IL-33, sodium 
channel and AQPs.
Bronchial expression of IL-33 was significantly 
increased in patients with PE compared to those without 
PE and healthy subjects. Furthermore, a positive correla-
tion was found between bronchial IL-33 expression and 
the number of CD68 + monocytes and neutrophils, sep-
tal congestion score, WBC score, and hyaline membrane 
formation score, suggesting IL-33 may play-role in lung 
destruction in severe malaria. Some studies showed that 
IL-33 may be elaborated T cells tracking to an inflam-
matory site, served as chemo-attractant for human T 
helper (Th)2 cells, a crucial cytokine for Th2-mediated 
host response, and a central role in epithelial cells con-
trolling immune responses [41, 42]. It is able to activate 
cells of both the innate and adaptive immune system, 
and depending on the disease can either promote the 
resolution of inflammation or drive disease pathology 
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Fig. 4 Expression of vascular smooth muscle cell (VSMC) γ-ENaC. a Photomicrograph of small arteries tunica media’s VSMC show positive cyto-
plasmic immunostaining pattern; b Bar chart comparing of VSMC γ-ENaC expression in normal, non-PE and PE lung samples; photomicrographs of 
immunohistochemical staining of VSMC γ-ENaC in both medium-size and large arteries in normal (c, d), non-PE (e, f) and PE (g, h) lung samples
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[35]. According to previous studies, falciparum malaria 
infection is characterized by elevation of Th2 cytokines 
expression [43, 44]. However the mechanism by which 
IL-33 is involved in lung injury in falciparum malaria 
remains unclear, thorough analysis of either Th1 and Th2 
cytokines or Th cell sub-sets with their relevant tran-
scription factors contributing to the level of bronchial 
epithelial IL-33 still needs to be further studied.
In the lung, IL-33 is mainly expressed in bronchial 
epithelial cells [45]. Thus, airway epithelial cells are 
also active players in the pathogenesis of lung malaria 
through epithelial cytokines, including IL-33 produced in 
response to various exogenous stimuli or to cellular dam-
age [46]. IL-33 is elevated in patients with pulmonary dis-
eases [35, 47]. A recent report on IL-33 transgenic mice 
showed pulmonary inflammation with a significant accu-
mulation of lymphocytes, monocytes and neutrophils 
but mild accumulation of eosinophils in the lung [47, 48]. 
This observation may correspond to a result of the sig-
nificant positive correlation between bronchial IL-33 and 
CD68, neutrophil and WBCs score. Although the results 
showed a negative correlation between bronchial IL-33 
and CD8 T cells, in P. falciparum infection, CD8 + cyto-
toxic T lymphocytes were significantly reduced indicat-
ing that immune suppression is more pronounced [44].
Patients with severe malaria due to P. falciparum, and 
more rarely due to P. vivax and Plasmodium knowlesi 
may develop ALI and ARDS, often several days after anti-
malarial drug treatment [2, 3]. The result demonstrated a 
significant positive correlation between bronchial IL-33 
and hyaline membrane formation, WBC and neutrophils 
together with a significantly higher incidence of hyaline 
membrane formation in PE than non-PE. These findings are 
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Fig. 5 Immunohistochemical staining for bronchial γ-ENaC. a Bar chart comparing of bronchial γ-ENaC expression in normal, non-PE and PE lung 
samples; photomicrographs of immunohistochemical staining of bronchial γ-ENaC localization in normal (b), non-PE (c) and PE (d) lung samples
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centres on inflammatory-mediated increased capillary per-
meability or endothelial damage, leading to DAD that can 
continue after parasite clearance [2].
Although this study demonstrated a similar range of 
leukocyte sub-sets (CD3, CD8, CD68, and neutrophil) 
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Fig. 6 Immunohistochemical staining for AQP-1 and -5 and bronchial cytokeratin. a Bar chart comparing the degree of alveolar expression of 
AQP-1 and -5 and bronchial expression of cytokeratin in normal, non-PE, and PE-lung samples; photomicrographs of immunohistochemical staining 
of AQP-1 and -5 (localized on alveolar vessel and alveolar epithelium, respectively) and bronchial cytokeratin among normal (b, e, h), non-PE (c, f, i) 
and PE (d, g, j) lung samples
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of WBC accumulation was significantly higher in severe 
malaria patients compared to normal cases. This sup-
ports the concept of excessive accumulation of WBCs in 
the lung as a feature contributing to severe malaria ALI. 
Interestingly, the correlation between bronchial IL-33 
and WBCs was found as previously described. These 
also appeared in a previous study on paediatric CM [49] 
which indicated that the number of pulmonary T-cells 
(as measured by CD3, CD4 or CD8) and pulmonary mac-
rophages (CD68) were similar across CM, non-CM, and 
non-malarial diagnosed cases.
The results demonstrate that the VSMC expression of 
γ-ENaC was significantly decreased in patients with PE 
compared with non-PE and healthy subjects. Moreo-
ver, bronchial expression of γ-ENaC was significantly 
decreased in patients with and without PE when com-
pared to healthy subjects. Due to the age of some of the 
cases, and prolonged storage, a constitutive antigen was 
examined to compare the potential loss of antigenicity in 
sections. However AE1/AE3 is a board spectrum pancy-
tokeratin stain and quantitatively showed no differences 
in lung of patients with or without PE, and healthy sub-
jects. Similarly, the expression of AQP-1 and -5 showed 
no significant differences amongst malarial patients with 
or without PE, or between malaria cases and controls.
There was a significant negative correlation between 
VSMC and bronchial γ-ENaC expression and the per-
centage of PRBC sequestration, alveolar thickness, 
alveolar expansion score, septal congestion score, and 
malarial pigment score, suggesting that γ-ENaC may play 
an important role in mediating clearance of oedema fluid 
from the lung in severe malaria.
The importance of γ-ENaC protein in VSMC-medi-
ated, pressure-induced constriction in arteries has been 
demonstrated [50, 51]. The myogenic response is an 
important regulatory mechanism for blood flow autoreg-
ulation to the circulation [52]. The reduction of VSMC 
γ-ENaC leads to decreased myogenic constriction and 
consequently to increased pressure transmission to the 
delicate microvasculature and increased susceptibil-
ity to end organ injury [53]. In the current study, VSMC 
γ-ENaC was significantly decreased in patients with PE. 
Lung injury in PE may result from an increased lung 
microvascular pressure due to downregulation of VSMC 
γ-ENaC, leading to an increase permeability of the gas-
blood barrier, which is likely to contribute to the forma-
tion or maintenance of either interstitial or alveolar PE.
The bronchial circulation also plays a significant role 
in the formation and re-absorption of both hydrostatic 
and permeability oedema [54] mediated by various ion 
pumps and channels such as AQPs, cystic fibrosis trans-
membrane conductance regulator (CFTR), ENaC, and 
cyclic nucleotide-gated (CNG) [55]. Severe malaria 
patients with PE had a reduced bronchial γ-ENaC 
expression. In addition, the low expression level of both 
VSMC and bronchial γ-ENaC was correlated to high per-
centage of alveolar vascular sequestration of PRBC and 
high malarial pigment scores, implying a high tissue par-
asite burden in these patients. The mechanisms by which 
pathogens affect ENaC expression are still being eluci-
dated; C57BL/6 mice infected with Plasmodium berghei 
K173 (PbK) demonstrated a reduction of activity and 
expression of ENaC suggesting that the infectious agents 
can have direct effects on ENaC in the lung epithelium 
[19]. These results imply that falciparum malaria causes a 
down regulation of γ-ENaC contributing to PE.
Hypoxia has been shown to reduce ENaC activity [56]. 
The results demonstrate that severe malaria patients 
who presented anaemia and pneumonia had reduced 
expression of bronchial γ-ENaC, and these clinical com-
plications can lead to hypoxemic condition and alveolar 
hypoxia, respectively.
In severe malaria patients, no difference was seen in 
the expression of AQP-1 and -5 between controls and 
malaria cases either with or without PE. This is in agree-
ment with many reports showing that AQP-1 and -5 does 
not appear to play a role in the physiological clearance of 
oedema in the lung or in the accumulation of extravas-
cular water in the injured lung [27–29, 57]. These stud-
ies suggest that AQP-1 and -5 only provide a pathway for 
osmotically induced water transport across the pleural 
barrier and do not affect pleural fluid dynamics in the 
endothelial cell injury.
These results suggest that induced bronchial IL-33 
expression may be involved in lung injury and the genesis 
of PE in severe malaria ALI. Moreover, the reduction both 
VSMC and bronchial γ-ENaC may retard fluid clearance 
from the lung and lead to PE in severe malaria. Alveolar 
AQP-1 and -5 did not show changes in expression, so 
do not appear to play a major role in deregulated water 
movement in malaria-induced lung injury. Results from 
this study identify a potential casual relationship between 
γ-ENaC and lung oedema pathogenesis in severe malaria. 
However other aspects require further study, for example 
the mechanism of channel gating by either mechanical 
stimuli or extrinsic factors. Not all patients with severe 
malaria develop lung injury and in this study, histopatho-
logical features were broadly similar between groups 
exhibiting PE or not, hence more detailed research is 
required to determine the factors which lead to PE or the 
development of more severe ARDS in individual patients.
Conclusions
Bronchial expression of the cytokine IL-33 is increased 
in malaria patients with oedema, may be involved in lung 
injury and the pathogenesis of oedema in severe malaria. 
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Moreover, reduced levels of the epithelial sodium chan-
nel γ-ENaC but not AQP-1 and -5, were seen, which may 
retard fluid clearance from the lung and contribute to 
oedema in severe malaria.
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